This post was originally published on this site
Biogen announced earnings per share of $4.77 on revenue of $2.51. Analysts polled by Investing.com anticipated EPS of $4.14 on revenue of $2.47B.
Biogen shares are down 13.16% from the beginning of the year, still down 3.50% from its 52 week high of $284.59 set on November 5, 2021.
Biogen’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
